- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Dolezal, T.
- Articles by Bryant, P. J.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Dolezal, T.
- Articles by Bryant, P. J.
Genetic Analysis of the ADGF Multigene Family by Homologous Recombination and Gene Conversion in Drosophila
Tomas Dolezal1,a,b, Michal Gazi1,a,b, Michal Zuroveca,b, and Peter J. Bryantaa Developmental Biology Center, University of California, Irvine, California 92697
b Institute of Entomology and University of South Bohemia, 37005 Ceske Budejovice, Czech Republic
Corresponding author: Peter J. Bryant, 4340 McGaugh Hall, University of California, Irvine, CA 92697., pjbryant{at}uci.edu (E-mail)
Communicating editor: T. KAUFMAN
| ABSTRACT |
|---|
Many Drosophila genes exist as members of multigene families and within each family the members can be functionally redundant, making it difficult to identify them by classical mutagenesis techniques based on phenotypic screening. We have addressed this problem in a genetic analysis of a novel family of six adenosine deaminase-related growth factors (ADGFs). We used ends-in targeting to introduce mutations into five of the six ADGF genes, taking advantage of the fact that five of the family members are encoded by a three-gene cluster and a two-gene cluster. We used two targeting constructs to introduce loss-of-function mutations into all five genes, as well as to isolate different combinations of multiple mutations, independent of phenotypic consequences. The results show that (1) it is possible to use ends-in targeting to disrupt gene clusters; (2) gene conversion, which is usually considered a complication in gene targeting, can be used to help recover different mutant combinations in a single screening procedure; (3) the reduction of duplication to a single copy by induction of a double-strand break is better explained by the single-strand annealing mechanism than by simple crossing over between repeats; and (4) loss of function of the most abundantly expressed family member (ADGF-A) leads to disintegration of the fat body and the development of melanotic tumors in mutant larvae.
OVER 5000 genes in the Drosophila genome appear to have arisen by gene duplication and are now members of multigene families (![]()
![]()
![]()
![]()
![]()
![]()
Growth factors are generally considered to function by interacting with specific cell-surface receptors, initiating signal transduction mechanisms that result in changes in gene transcription. However, other mechanisms of growth stimulation are possible. For example, the ADGFs appear to stimulate cell growth by an indirect mechanism, depleting the levels of extracellular adenosine that otherwise have a negative effect on growth of several cell types (![]()
![]()
From sequence analysis of ADGF genes, ![]()
![]()
![]()
![]()
Because of the possibility of genetic redundancy within the ADGF gene family, it was necessary to use a mutagenesis system that recovers knockout mutations independent of phenotype. We therefore used the method of homologous recombination (HR) recently developed for Drosophila (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
|
|
| MATERIALS AND METHODS |
|---|
Design of homologous recombination constructs:
We used the ends-in targeting procedure (![]()
1.3 kb (![]()
Constructs:
The pTV2(ADGF-A2-, -A-, -B-) plasmid for HR in the ADGF-A region was constructed as follows (Fig 2A): four fragments containing all three genes were PCR amplified from Oregon-R genomic DNA using the following primers: 5'-CTTCGCTCCTGGTGGTGGTC and 5'-CCCGGGCAAATCCAGCAAAGAAATTCG (introducing a +1 frameshift mutation and a new SmaI restriction site into the ADGF-A2 gene, 1299 bp downstream of the start codon); 5'-CACGCTAGCTTAACACCTTTGGGGACGAG and 5'-GGGTTTGGAGCTAGCCAGTTACGC (introducing an in-frame stop codon and a new NheI restriction site into the ADGF-A gene, 1160 bp downstream of the start codon); 5'-GCGTAACTGGCTAGCTCCAACCC and 5'-CTCGCTAGCTCTTGAACGCCGTGGGTGAC(introducing an in-frame stop codon and a new NheI restriction site into the ADGF-B gene, 125 bp downstream of the start codon); and 5'-AGAGCTAGCGACAAGCAATCGCCAAGGTG and 5'-CAGGTACCGGCCAGGCTTTTGAGGAACC (creating a KpnI restriction site at the end of construct for later cloning into pTV2). All four fragments were cloned step by step into the modified pBLUESCRIPT II KS- (the XbaI-EcoRI fragment was replaced by a XbaI-EcoRI fragment from a pSLfa1180fa plasmid containing an NheI site) using restriction sites added to amplified fragments. An I-SceI site was added by the annealing and cloning of the complementary oligonucleotides 5'-TCGAATTACCCTGTTATCCCTA (containing an XhoI cohesive end) and 5'-CGCGTAGGGATAACAGGGTAAT (containing a MluI cohesive end) into MluI and XhoI sites originally present 151 and 167 bp upstream of the ADGF-A start codon. The entire fragment was then cut from the modified pBLUESCRIPT by NotI and KpnI and cloned into the pTV2 plasmid (provided by Yikang Rong and Kent Golic).
The pTV2(ADGF-C-, -D-) construct for HR in the ADGF-C+D region was constructed as follows (Fig 2C): the entire region containing both genes and flanking sequences was amplified in four fragments from Oregon-R genomic DNA. Fragment I was amplified using the oligonucleotides 5'-AGGGTACCATGTCAAGGACGTGGAGGT (introducing a KpnI restriction site) and 5'-CAATGCTAGCTCTGCACTTTTTCAAGGC (containing an NheI restriction site). Fragment II was amplified using oligonucleotides 5'-GTCCTCGAGTTACAGATTATTGGTGGTGGTCA (containing an XhoI restriction site and introducing a stop codon into the ADGF-D, 453 bp downstream of +1 site) and 5'-CATGGCTAGCCCGCATTTTGCTCCGCATTC (containing a NheI restriction site and introducing a stop codon into the ADGF-C gene, 412 bp downstream of +1 site; the original NotI restriction site was removed in this step). Fragments I and II were cloned together into the pSLfa1180fa vector. Fragment III was amplified using primers 5'-CGACTAGTGCCATCTGTTCGACTGCTCC (containing a SpeI restriction site) and 5'-GCACTCGAGTCGCAATGTGGATGGACTG (containing an XhoI restriction site) and cloned into pBLUESCRIPT II KS-. Fragment IV was amplified using primers 5'-AAGGAAAAGCGGCCGCTTCCCTTTGAACTTACCTCTGG (containing a NotI restriction site) and 5'-CCGCTCGAGGTCCATTCCGAATGGCAAATC (containing an XhoI restriction site) and added together with an oligonucleotide providing an I-SceI recognition site to pBLUESCRIPT II KS- that already carried fragment III. An I-SceI recognition site was made by the annealing of the complementary oligonucleotides 5'-TCGAATTACCCTGTTATCCCTA (containing XhoI cohesive end) and 5'-CGCGTAGGGATAACAGGGTAAT (containing a MluI cohesive end). Fragments I and II were then recloned (using KpnI and XhoI restriction endonucleases) from the pSLfa1180fa vector into pBLUESCRIPT II KS- with fragments III, IV, and I-SceI oligo already present. After assembling the mutated ADGF-C and ADGF-D region in pBLUESCRIPT II KS-, the construct was recloned (using KpnI and NotI restriction endonucleases) into pTV2 plasmid (provided by Yikang Rong and Kent Golic).
Production of transgenic lines and mutagenesis crosses:
DNA constructs for HR were injected into y w fly embryos using the modified P-element-mediated transformation procedure (![]()
In the first step, we used the rapid targeting scheme (![]()
![]()
|
In the second step, selected lines (with targeted events) were crossed with the line carrying the gene encoding I-CreI endonuclease on the X chromosome to induce a DSB in the recognition sequence between the two components of the duplication. This DSB induces reduction of the duplication to a single copy. Flies with such a reduction were scored by loss of the miniwhite marker.
Fly stocks:
The stocks y w (v); P[ry+, 70FLP]4 P[v+, 70I-SceI]2B Sco/S2 CyO and w1118; P[ry+, 70FLP]10 (constitutively active FLP recombinase, homozygous on the second chromosome) for the rapid targeting scheme (Fig 3) in the first step and v P[70I-CreI, v+]2A; ry for reducing the duplication in the second step were provided by Yikang Rong and Kent Golic. The stocks y w; Xa/Cyo;MKRS and w; TM3 Sb Ser/TM6B were used for mapping to chromosome and for establishing the recombinant lines.
Molecular characterization of the targeted events:
The first step of HR was analyzed using standard methods of DNA isolation, digestion, and Southern blot analysis (![]()
The second-step recombination events were detected by PCR analysis using primers with mutation-specific 3' ends: ADGF-A region5'-GAATTTCTTTGCTGGATTTGCC (last CC specific for ADGF-A2 mutation), 5'-CCTTTATTTGTTTAAGGGTTTGGAGC (last GC specific for ADGF-A mutation), and 5'-CCACGGCGTTCAAGAGC (last GC specific for ADGF-B mutation); ADGF-C+D region5'-ATGCGGAGCAAAATGCGGGCTA (last G and TA specific for ADGF-C mutation) and 5'-CACCAATAATCTGTAACTCGAG (last ACT and GAG triplets specific for ADGF-D mutation). The PCR analysis of the reduction events was confirmed in selected samples by Southern blot. In each case the sample DNA was a mixture of genomic DNA from heterozygous and homozygous adult flies. The reduction events in the ADGF-A region were analyzed using HpaI, NheI, and SmaI restriction enzymes, and the membrane was hybridized with two probes covering the whole region prepared by PCR from genomic DNA (Fig 7). The reduction events in the ADGF-C+D region were analyzed using XhoI and NheI restriction enzymes and a PCR-amplified probe for each of the two genes (Fig 7).
|
|
|
|
Two alternative start sites of the ADGF-A gene were analyzed by RT-PCR: total RNA from homozygous lines 1 and 14 and from wild-type third instar larvae was isolated using an RNAeasy kit (QIAGEN, Chatsworth, CA). The first strand was produced by Superscript reverse transcriptase (Invitrogen, San Diego) using the ADGF-A-specific primer 5'-AGGTTCTCATCCACAGTGG. Primers 5'-GAAGATCGCGGCGAGGAAGT and 5'-CGAACGCGTGTTAAATCAAAG, specific for the first noncoding exon of ADGF-A and an alternative transcriptional start site of ADGF-A, respectively, were used for PCR with the first strand as a template.
| RESULTS |
|---|
Recombinationfirst step:
To induce HR, we established 315 vials (containing four to five females each) for the ADGF-A region and 350 vials for the ADGF-C+D region, and we recovered 18 potential recombinant lines for the ADGF-A region and 19 for the ADGF-C+D region. All potential recombinant lines were tested by Southern blot (Fig 4 and Fig 5), and Table 1 summarizes the overall frequencies of targeted and nontargeted events. For the ADGF-A region, the duplication with the expected combination of mutations (Fig 2B) was detected in 5 of 14 targeted events (lines 6, 10, 13, 14, and 16; Table 2). Two triplications (lines 7 and 8), containing an additional insertion of the original donor carrying all three mutations (a class IV event according to ![]()
450 bp was detected in the ADGF-A2 wild-type copy (a class III event). The remaining seven lines with targeted events carried the expected duplication but with various gene conversions (see Fig 4 and Table 2 for details) in which we assume that the introduced mutation was converted back to wild type using the wild-type chromosome as a template or that the wild-type copy in the duplication was converted to a mutant using the donor DNA as a template. In line 9, the mutation in the ADGF-A gene was found on the opposite side of the duplication than expected. Two other lines carried the mutation in both copies of ADGF-A in the duplication (lines 1 and 15 are also called karel and gerda, respectively).
|
The two lines carrying both mutated copies of ADGF-A (karel and gerda) showed a larval lethal phenotype in the homozygotes (described below). All other lines with targeted events were homozygous viable. However, we expected that a mutation in only one copy of the ADGF-A gene (on the left side, Fig 2) would cause the same phenotype as a mutation in both copies of this gene. This was because the construct was designed so that the wild-type copy of the ADGF-A gene on the right side of the duplication lacks the first noncoding exon, which in the normal genome is shared by ADGF-A and ADGF-A2 (see Fig 1 and Fig 2). By searching the expressed sequence tag (EST) database, we found one EST clone of ADGF-A, which has an alternative transcriptional start site 55 bp prior to the second exon (the first exon is not present in this clone). We confirmed this alternative transcriptional start site by RT-PCR using primers specific to each transcriptional start site (see MATERIALS AND METHODS). Both variants were overexpressed in larvae homozygous for the ADGF-A mutation (line Karel; data not shown). This overexpression may be a regulatory response to the lack of functional ADGF-A protein, suggesting that the expression of ADGF-A is tightly controlled. The transcriptional start using the first exon seems to be used more than the alternative transcriptional start site; there are 16 clones with the first-exon transcriptional start in the EST database compared to only 1 clone with the alternative transcriptional start site. Lines with the expected duplication in the ADGF-A region showed that the ADGF-A mutant phenotype is fully suppressed by the presence of a wild-type ADGF-A transcript starting from the alternative start site. Unfortunately, none of the combinations we obtained allowed us to test whether the transcript containing the first exon, when expressed alone, would also be sufficient to suppress the phenotype.
For the ADGF-C+D cluster we obtained 19 fly lines with a nonmosaic eye color, which was the marker for potentially targeted duplications. In genetic crosses we excluded lines with the insertion on X or the second chromosome (8 lines). The remaining 11 lines, all with the insertion on the third chromosome, were subject to Southern blot analysis. In the first round of Southern blots we used enzymes SpeI, NheI, and XhoI and we found three lines with the correct hybridization pattern. Since there was a possibility that in the next 8 lines a deletion had occurred in the DSB area (a class III event), we performed another Southern blot using the NdeI restriction enzyme instead of SpeI, since this should change the size of DNA fragments in a specific way according to the size of the deletion. Using these two different enzyme sets for Southern blot analysis, we showed that the remaining 8 lines have apparently random insertions into the third chromosome (i.e., they are nontargeted events). The data are summarized in Table 3 and Fig 5, which shows only the Southern blot using NdeI, NheI, and XhoI.
|
Recombinationsecond step:
We crossed lines selected from the previous step with the line carrying the I-CreI endonuclease on the X chromosome to induce a DSB in the recognition sequence between repeats (see Fig 2). The selected lines for the ADGF-A region were line 9, called Amalie, and line 14, called Franta; for the ADGF-C+D region, they were lines 4, 5, and 7. The most frequent repair mechanism of the DSB between direct repeats is reduction to a single copy by either simple crossing over between repeats or single-strand annealing (SSA; ![]()
For the ADGF-C+D region, we screened 130 reduction events for the presence of mutations by PCR using mutation-specific primers. We obtained nine lines with mutations in both ADGF-C and ADGF-D, and seven lines with a mutation in ADGF-D. In two cases we detected a single mutation in ADGF-C, indicating that multiple exchanges can occur. PCR screening of the reduction events was further confirmed by Southern blot analysis in selected samples (Fig 7).
In summary, all potential combinations of mutations in both ADGF-A and ADGF-C+D regions, i.e., a single mutation in each gene, all double-mutant combinations, and one triple-mutant combination in the ADGF-A region, were obtained from this second step, allowing us to analyze the phenotypes produced by both single mutations and all combinations of multiple mutations in these five members of the ADGF family.
Mutant phenotype:
Both karel and gerda homozygotes (A2 A* B* w A2* A* B and A2 A* B* w A2 A* B genotypes, respectively), as well as heterozygous gerda/karel flies, show a clear mutant phenotype, presumably due to LOF for ADGF-A. They are mostly lethal in late third instar, and larval development is significantly delayed. They show disintegration of the fat body and most third instar larvae develop melanotic tumors (Fig 8). They rarely pupate, but when they do, they produce abnormal pupae. It is important to note that these two lines are totally independent, since they were produced from different transgenic flies. However, they both carry mutations in both copies of ADGF-A (see Recombinationfirst step). The homozygous phenotype is also the same in all lines carrying mutant ADGF-A after reduction to single copy. The other confirmation that the phenotype is caused by the mutation in the ADGF-A gene is the rescue of the phenotype to wild type by the expression of a transgenic ADGF-A gene under either a heat-shock or a UAS promoter (driven by actin-Gal4 driver; data not shown).
|
Double mutants in ADGF-C and ADGF-D have prolonged development and show semilethality during larval and pupal stages. They are also lethargic during the first few days after emerging, and their fertility is significantly lower than that of heterozygous siblings. The effect of both mutations seems to be cumulative since mutants in either the ADGF-C or the ADGF-D gene have similar phenotypes with lower penetrance than that seen in double mutants. A similar phenotype was observed in experiments with RNAi-mediated silencing of ADGF-C and ADGF-D genes (data not shown).
Mutations in the ADGF-A2 and ADGF-B genes (both single mutants and double mutants) do not express any obvious phenotype, and homozygous adults are fertile. A homozygous triple-mutant combination (A2* A* B*) expresses the same phenotype as does a single homozygous mutation in ADGF-A (karel and gerda).
| DISCUSSION |
|---|
Our work confirms that ends-in targeting is a very powerful tool for introducing specific mutations into the genome, and it adds to our knowledge of the process of HR. Introducing two or three mutations into one construct allowed us to analyze targeting events in detail, especially gene conversions as well as recombination events during reduction of duplication to single copy. We have also shown that it is possible to introduce multiple changes into the genome simultaneously by this method and, in our case, to disrupt a multigene family.
It has already been pointed out that mutations close to DSB can be repaired to wild type by gene conversion using the homologous chromosome as a template. ![]()
1.3 kb. Our results support this conclusion since conversion was frequent (11 conversions in 14 targeted events) in the case of ADGF-A2 and ADGF-A mutations, which were 1.0 and 1.3 kb, respectively, from the DSB, whereas no conversion was detected in ADGF-B, ADGF-C, and ADGF-D mutations, which were from 3 to 6 kb from the DSB. Our results also show that the wild-type copy on a chromosome can be converted to a mutant copy, presumably using the donor construct as a template. This was observed in lines 1 and 15 where the wild-type copy of the ADGF-A gene was converted to a mutated copy, resulting in a duplication with mutated copies on both sides. It is more difficult to explain the reciprocal exchange of the ADGF-A mutation in the line 9 (Amalie) duplication. If the duplication arises by insertion of the donor construct into the I-SceI site, then reciprocal conversion (conversion in the chromosome using the donor as a template and conversion in the donor using the chromosome as a template, respectively) would occur. This would be possible only in the G2 phase of the cell cycle, when more than one template is available. It could also include a two-copy donor intermediate, perhaps followed by I-SceI cutting and repair after a class IV event is generated by the initial targeting. In any case, the data show that gene conversion must be anticipated when designing a donor construct and that this phenomenon can also be used for specific purposes. In our case, we used gene conversion to increase the number of mutation combinations in the following step of reduction to a single copy.
The efficiency of targeting in these experiments differs between the ADGF-A and ADGF-C+D regions. Although the numbers of recovered events are similar (approximately one event per 18 vials), the frequencies of nontargeted insertions are significantly different. In the ADGF-A region we obtained 14 targeted events out of 18 examined lines, and all nontargeted events were mapped to the same chromosome as the original (donor) insertion. This suggests that the donor construct was not excised by the FLP recombinase but that DSB occurred at the I-SceI site. This would have been partially repaired using the wild-type template, removing one FRT sequence and leaving the miniwhite marker, which is then detected in the rapid targeting screen (only one FRT sequence is present). However, the results for the ADGF-C+D region are different. We found only three targeted events out of 19 examined lines with nonmosaic eyes, and most of the nontargeted events were localized to a different chromosome than was the original insertion. The explanation for such a low efficiency may be that we started the first step of HR with only two different donor lines (Table 1) and that the targeting efficiency for one of them was <12% (2/15). An alternative explanation may be that the ADGF-C+D chromosomal region is somehow protected from any structural changes. This idea is supported by our previous unsuccessful mutagenesis of the ADGF-C+D region using both male recombination and mobilization of a 7-kb-distant P element. In conclusion, our results confirm that targeting efficiency depends on the position of the original donor insertion and on the chromosomal structure of the targeted region.
Because in most cases the duplication after the first step contained wild-type copies of the genes, we induced reduction to single copy by I-CreI endonuclease (![]()
![]()
![]()
![]()
|
The ADGF-C+D region behaved significantly differently from the ADGF-A region. Mutations in either one or both ADGF-C and ADGF-D genes were preserved in only 13% of reduction events. The recovery of such a small number of mutant alleles may indicate that the heterozygous combination can influence the length of development or the viability of mutation carriers. During the screening for mutants after the second step of HR, we took only one fly from each vial to get the highest possible variability. We usually selected the first emerged fly with the loss of red eye color. Thus we could have accidentally favored wild-type alleles. This could also explain why we did not succeed with P-element mutagenesis of the ADGF-C+D region.
The results of the reduction screen are consistent with our molecular analysis of the duplications since we recovered the expected combinations (Fig 6). In addition, the reduction of karel with both copies of ADGF-A mutated produced only flies with the karel phenotype (data not shown).
The mutant phenotypes that we discovered correspond to the expression patterns of individual genes. Since the ADGF-A gene is expressed at all developmental stages (![]()
![]()
Detailed analysis of phenotypes and of the ADGF-A and ADGF-C+D region mutant combinations are under further investigation. Our results show that by classical mutagenesis methods based on phenotype screening only the ADGF-A gene among six members of the ADGF family would have been identified. However, using the HR method for gene targeting we were able to recover five mutants out of six members of the ADGF family, which will allow us to perform further investigations into the roles of individual family members.
| FOOTNOTES |
|---|
1 These authors contributed equally to this work. ![]()
| ACKNOWLEDGMENTS |
|---|
We thank Kent Golic and Yikang Rong for providing us with all of the necessary fly strains and vectors necessary for homologous recombination, Sangbin Park for his excellent help with embryo transformation, Ivana Gaziova, Eva Pavlova, Ruzenka Kuklova, and Robert Fedic for help with maintaining fly strains, and Leanne Compton for help with manuscript writing. This work was supported by grants from the National Science Foundation (440860-21565), the Grant Agency of the Czech Republic (204/01/1022), the Grant Agency of the Czech Academy of Sciences (A5007107), and the Ministry of Education, Youth and Sports of the Czech Republic (Kontakt ME549).
Manuscript received March 11, 2003; Accepted for publication June 2, 2003.
| LITERATURE CITED |
|---|
BROGIOLO, W., H. STOCKER, T. IKEYA, F. RINTELEN, and R. FERNANDEZ et al., 2001 An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr. Biol. 11:213-221.[Medline]
EGLI, D., A. SELVARAJ, H. YEPISKOPOSYAN, B. ZHANG, and E. HAFEN et al., 2003 Knockout of metal-responsive transcription factor MTF-1 in Drosophila by homologous recombination reveals its central role in heavy metal homeostasis. EMBO J. 22:100-108.[Medline]
GLOOR, G. B., N. A. NASSIF, D. M. JOHNSONSCHLITZ, C. R. PRESTON, and W. R. ENGELS, 1991 Targeted gene replacement in Drosophila via P-element-induced gap repair. Science 253:1110-1117.
KAWAMURA, K., T. SHIBATA, O. SAGET, D. PEEL, and P. J. BRYANT, 1999 A new family of growth factors produced by the fat body and active on Drosophila imaginal disc cells. Development 126:211-219.[Abstract]
MAIER, S. A., L. PODEMSKI, S. W. GRAHAM, H. E. MCDERMID, and J. LOCKE, 2001 Characterization of the adenosine deaminase-related growth factor (ADGF) gene family in Drosophila. Gene 280:27-36.[Medline]
MATSUSHITA, T., I. FUJII-TAIRA, Y. TANAKA, K. J. HOMMA, and S. NATORI, 2000 Male-specific IDGF, a novel gene encoding a membrane-bound extracellular signaling molecule expressed exclusively in testis of Drosophila melanogaster. J. Biol. Chem. 275:36934-36941.
PAQUES, F. and J. E. HABER, 1999 Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 63:349-404.
PARK, S. and J. K. LIM, 1995 A microinjection technique for ethanol-treated eggs and a mating scheme for detection of germ line transformants. Dros. Inf. Serv. 76:187-189.
PRESTON, C. R., W. ENGELS, and C. FLORES, 2002 Efficient repair of DNA breaks in Drosophila: evidence for single-strand annealing and competition with other repair pathways. Genetics 161:711-720.
RIAZI, M. A., P. BRINKMAN-MILLS, T. NGUYEN, H. Q. PAN, and S. PHAN et al., 2000 The human homolog of insect-derived growth factor, CECR1, is a candidate gene for features of cat eye syndrome. Genomics 64:277-285.[Medline]
RONG, Y. S. and K. G. GOLIC, 2000 Gene targeting by homologous recombination in Drosophila. Science 288:2013-2018.
RONG, Y. S. and K. G. GOLIC, 2001 A targeted gene knockout in Drosophila. Genetics 157:1307-1312.
RONG, Y. K. S., S. W. TITEN, H. B. XIE, M. M. GOLIC, and M. BASTIANI et al., 2002 Targeted mutagenesis by homologous recombination in D. melanogaster. Genes Dev. 16:1568-1581.
RUBIN, G. M., M. D. YANDELL, J. R. WORTMAN, G. L. GABOR MIKLOS, and C. R. NELSON et al., 2000 Comparative genomics of the eukaryotes. Science 287:2204-2215.
SAMBROOK, J., E. F. FRITSCH and T. MANIATIS, 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
SEUM, C., D. PAULI, M. DELATTRE, Y. JAQUET, and A. SPIERER et al., 2002 Isolation of Su(var)3-7 mutations by homologous recombination in Drosophila melanogaster. Genetics 161:1125-1136.
ZUROVEC, M., T. DOLEZAL, M. GAZI, and P. BRYANT, 2001 ADGFsgrowth factors with enzymatic activity. Annu. Dros. Res. Conf. 42:69.
ZUROVEC, M., T. DOLEZAL, M. GAZI, E. PAVLOVA, and P. J. BRYANT, 2002 Adenosine deaminase-related growth factors stimulate cell proliferation in Drosophila by depleting extracellular adenosine. Proc. Natl. Acad. Sci. USA 99:4403-4408.
This article has been cited by other articles:
![]() |
R. Iijima, T. Kunieda, S. Yamaguchi, H. Kamigaki, I. Fujii-Taira, K. Sekimizu, T. Kubo, S. Natori, and K. J. Homma The Extracellular Adenosine Deaminase Growth Factor, ADGF/CECR1, Plays a Role in Xenopus Embryogenesis via the Adenosine/P1 Receptor J. Biol. Chem., January 25, 2008; 283(4): 2255 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Hittinger, D. L. Stern, and S. B. Carroll Pleiotropic functions of a conserved insect-specific Hox peptide motif Development, December 1, 2005; 132(23): 5261 - 5270. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Gong and K. G. Golic Genomic Deletions of the Drosophila melanogaster Hsp70 Genes Genetics, November 1, 2004; 168(3): 1467 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Xie and K. G. Golic Gene Deletions by Ends-In Targeting in Drosophila melanogaster Genetics, November 1, 2004; 168(3): 1477 - 1489. [Abstract] [Full Text] [PDF] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Dolezal, T.
- Articles by Bryant, P. J.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Dolezal, T.
- Articles by Bryant, P. J.











